Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Return on Equity for 15 consecutive years, with 0.02% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 7.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02%, a 7.0% increase, with the full-year FY2025 number at 0.02%, up 7.0% from a year prior.
  • Return on Equity was 0.02% for Q4 2025 at AtriCure, up from 0.06% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.12% in Q2 2022 to a low of 0.15% in Q2 2021.
  • A 5-year average of 0.05% and a median of 0.08% in 2024 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 26bps in 2022; the steepest drop was -23bps in 2022.
  • AtriCure's Return on Equity stood at 0.1% in 2021, then plummeted by -199bps to 0.1% in 2022, then skyrocketed by 36bps to 0.07% in 2023, then crashed by -47bps to 0.1% in 2024, then surged by 76bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Return on Equity are 0.02% (Q4 2025), 0.06% (Q3 2025), and 0.08% (Q2 2025).